| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |